National Comprehensive Cancer Network presents award to Fox Chase professor
Click Here to Manage Email Alerts
Mary B. Daly, MD, PhD, FACP, received National Comprehensive Cancer Network’s Rodger Winn Award.
The annual award recognizes an NCCN Clinical Practice Guidelines in Oncology panel member who exemplifies commitment, drive and leadership in developing evidence-based guidelines.
Daly is professor in the department of clinical genetics and director of the risk assessment program at Fox Chase Cancer Center. She also is Timothy R. Talbot Jr. chair in cancer research.
The award recognizes her leadership in developing NCCN’s genetic and familial high-risk guidelines for hereditary cancers.
“Throughout her career, Mary has been a pioneer in developing multidisciplinary care for people at increased genetic risk for cancer,” Robert W. Carlson, MD, CEO of NCCN, said in a press release. “It is with her leadership in the quickly evolving practice of hereditary cancers that the genetic and familial high-risk guidelines have become a key resource used daily by the cancer genetics community.”
The award is named for a medical oncologist who oversaw the development of the first generation of NCCN guidelines.
“I had the opportunity to know Rodger early in my career, and his example has always been a guiding force for me,” Daly said in the release. “He understood what kind of guidance health care providers needed in the care of their patients and helped to establish the model of scientific rigor [that] has characterized NCCN since its inception. Nothing would mean more to me than to be able to be a role model to others in the field of cancer prevention as Rodger was to me.”
Click Here to Manage Email Alerts